| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |